Literature DB >> 7729480

Onchocerca volvulus: parasitologic and serologic responses in experimentally infected chimpanzees and mangabey monkeys.

M L Eberhard1, J W Dickerson, V C Tsang, E M Walker, E A Ottesen, R Chandrashekar, G J Weil, M Trpis, E Strobert, I Constantinidis.   

Abstract

Six chimpanzees (Pan troglodytes) and six mangabey monkeys (Cercocebus atys) were inoculated with Onchocerca volvulus third-stage larvae (L3) of West African origin. Two chimpanzees each received 200, 300, or 400 L3, while three mangabeys each received either 50 or 250 L3. All six chimpanzees became microfilaria positive between 11 and 25 months postinoculation (PI), while two of the six mangabeys were skin-snip positive at 24 and 37 months PI, respectively. All chimpanzees developed antibodies to two native antigens of 14 and 22 kDa and to the recombinant antigens OV16, OC3.6, and OC9.3. Marked antibody responses were observed in the mangabey monkeys, and in general, the responses were similar to those observed in the chimpanzees. However, in the mangabeys, these responses did not generally manifest themselves until later in the infection. The results of this study suggest that in chimpanzees, the smallest inoculum used, 200 L3, was sufficient to initiate consistent infections that had parasitologic and immunologic parameters equivalent to animals inoculated with larger numbers of larvae. Similarly, inoculation of mangabey monkeys with small numbers of larvae appeared to be as likely to establish infection and induce immunologic responses as did inoculation of larger numbers of larvae. Microfilaria-positive chimpanzees and mangabey monkeys were examined by three conventional imaging techniques (X ray, ultrasound, and magnetic resonance imaging (MRI)), but no adult worms or nodules could be identified in any animal.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729480     DOI: 10.1006/expr.1995.1057

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

Review 1.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Differences in the Clinical and Laboratory Features of Imported Onchocerciasis in Endemic Individuals and Temporary Residents.

Authors:  Adrienne J Showler; Joseph Kubofcik; Alessandra Ricciardi; Thomas B Nutman
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

3.  Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of Onchocerca volvulus Infection.

Authors:  Vitaliano A Cama; Circe McDonald; Alice Arcury-Quandt; Mark Eberhard; M Harley Jenks; Jared Smith; Sindew M Feleke; Francisca Abanyie; Lakwo Thomson; Ryan E Wiegand; Paul T Cantey
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

4.  Case report: First evidence of human zoonotic infection by Onchocerca lupi (Spirurida, Onchocercidae).

Authors:  Domenico Otranto; Nermin Sakru; Gabriella Testini; Vuslat P Gürlü; Konuralp Yakar; Riccardo P Lia; Filipe Dantas-Torres; Odile Bain
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

5.  Operational Performance of the Onchocerca volvulus "OEPA" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.

Authors:  Frank O Richards; Moses Katabarwa; Firdaweke Bekele; Zerihun Tadesse; Aderajew Mohammed; Mauricio Sauerbrey; Alfredo Dominguez-Vazquez; Mario A Rodriguez-Perez; Nadia A Fernández-Santos; Nidia Rizzo; Harland R Schuler Martínez; Raquel Lovato Silva; Zoraida Morales Monroy; Peace Habomugisha; David W Oguttu; Issam M A Zarroug; Nabil A Aziz; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

6.  Human ocular filariasis: further evidence on the zoonotic role of Onchocerca lupi.

Authors:  Domenico Otranto; Filipe Dantas-Torres; Zafer Cebeci; Baris Yeniad; Nesimi Buyukbabani; Ozden Buyukbaba Boral; Andrea Gustinelli; Trimèche Mounir; Yasen Mutafchiev; Odile Bain
Journal:  Parasit Vectors       Date:  2012-04-27       Impact factor: 3.876

7.  Integrating Multiple Biomarkers to Increase Sensitivity for the Detection of Onchocerca volvulus Infection.

Authors:  Sasisekhar Bennuru; Georgiette Oduro-Boateng; Chinweoke Osigwe; Priscilla Del Valle; Allison Golden; Guilherme Maerschner Ogawa; Vitaliano Cama; Sara Lustigman; Thomas B Nutman
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 7.759

8.  An Integrated Multiomics Approach to Identify Candidate Antigens for Serodiagnosis of Human Onchocerciasis.

Authors:  Samantha N McNulty; Bruce A Rosa; Peter U Fischer; Jeanne M Rumsey; Petra Erdmann-Gilmore; Kurt C Curtis; Sabine Specht; R Reid Townsend; Gary J Weil; Makedonka Mitreva
Journal:  Mol Cell Proteomics       Date:  2015-10-15       Impact factor: 5.911

9.  Establishment of an in vitro culture system to study the developmental biology of Onchocerca volvulus with implications for anti-Onchocerca drug discovery and screening.

Authors:  Narcisse V T Gandjui; Abdel J Njouendou; Eric N Gemeg; Fanny F Fombad; Manuel Ritter; Chi A Kien; Valerine C Chunda; Jerome Fru; Mathias E Esum; Marc P Hübner; Peter A Enyong; Achim Hoerauf; Samuel Wanji
Journal:  PLoS Negl Trop Dis       Date:  2021-02-09

Review 10.  Diagnostics for onchocerciasis in the era of elimination.

Authors:  Thomas R Unnasch; Allison Golden; Vitaliano Cama; Paul T Cantey
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.